Dinakantha Kumararatne

16.4k total citations · 1 hit paper
57 papers, 4.3k citations indexed

About

Dinakantha Kumararatne is a scholar working on Immunology, Epidemiology and Infectious Diseases. According to data from OpenAlex, Dinakantha Kumararatne has authored 57 papers receiving a total of 4.3k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Immunology, 25 papers in Epidemiology and 18 papers in Infectious Diseases. Recurrent topics in Dinakantha Kumararatne's work include Immunodeficiency and Autoimmune Disorders (28 papers), Mycobacterium research and diagnosis (11 papers) and Tuberculosis Research and Epidemiology (8 papers). Dinakantha Kumararatne is often cited by papers focused on Immunodeficiency and Autoimmune Disorders (28 papers), Mycobacterium research and diagnosis (11 papers) and Tuberculosis Research and Epidemiology (8 papers). Dinakantha Kumararatne collaborates with scholars based in United Kingdom, France and United States. Dinakantha Kumararatne's co-authors include Jean‐Laurent Casanova, David A. Lammas, Rainer Döffinger, Tom H. M. Ottenhoff, Ian C. M. MacLennan, Hervé Bazin, Carmel B. Stober, Emmanuelle Jouanguy, Capucine Pïcard and Sergey Nejentsev and has published in prestigious journals such as Science, The Lancet and Nature Communications.

In The Last Decade

Dinakantha Kumararatne

54 papers receiving 4.2k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Impairment of Mycobacterial Immunity in Human Interleukin-12 Receptor Deficiency

1998 644 citations David A. Lammas, Emmanuelle Jouanguy et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Dinakantha Kumararatne United Kingdom	28	2.3k	1.4k	1.3k	665	560	57	4.3k
Rainer Döffinger United Kingdom	28	2.4k 1.0×	1.5k 1.1×	1.3k 1.0×	645 1.0×	704 1.3×	83	4.3k
Jacinta Bustamante France	35	3.5k 1.5×	1.8k 1.3×	1.5k 1.1×	694 1.0×	581 1.0×	162	4.7k
László Maródi Hungary	37	1.9k 0.8×	1.3k 0.9×	883 0.7×	786 1.2×	792 1.4×	136	4.4k
Karl A. Brokstad Norway	37	1.7k 0.7×	1.6k 1.1×	738 0.6×	545 0.8×	1.1k 2.0×	112	5.1k
René R. P. de Vries Netherlands	51	3.3k 1.4×	1.0k 0.7×	972 0.7×	1.1k 1.7×	823 1.5×	138	7.3k
Hidetoshi Takada Japan	33	3.0k 1.3×	712 0.5×	660 0.5×	616 0.9×	937 1.7×	218	5.1k
Raffaele Badolato Italy	43	3.2k 1.4×	857 0.6×	724 0.5×	865 1.3×	1.2k 2.2×	165	6.0k
Theo S. Plantinga Netherlands	36	1.9k 0.8×	1.7k 1.2×	1.2k 0.9×	433 0.7×	1.2k 2.2×	92	4.4k
Todd A. Reinhart United States	38	3.6k 1.5×	1.5k 1.1×	1.5k 1.2×	263 0.4×	953 1.7×	98	6.0k
Stephan Ehl Germany	49	5.0k 2.2×	1.3k 0.9×	1.5k 1.1×	815 1.2×	1.3k 2.2×	160	7.5k

Countries citing papers authored by Dinakantha Kumararatne

Since Specialization

Citations

This map shows the geographic impact of Dinakantha Kumararatne's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dinakantha Kumararatne with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dinakantha Kumararatne more than expected).

Fields of papers citing papers by Dinakantha Kumararatne

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dinakantha Kumararatne. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dinakantha Kumararatne. The network helps show where Dinakantha Kumararatne may publish in the future.

Co-authorship network of co-authors of Dinakantha Kumararatne

This figure shows the co-authorship network connecting the top 25 collaborators of Dinakantha Kumararatne. A scholar is included among the top collaborators of Dinakantha Kumararatne based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dinakantha Kumararatne. Dinakantha Kumararatne is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Karofylakis, Emmanouil, Effrossyni Gkrania‐Klotsas, Benjamin J. Uttenthal, & Dinakantha Kumararatne. (2024). Resolution of hypogammaglobulinemia-associated recurrent Campylobacter bacteraemia after hematopoietic cell transplantation (HCT). SHILAP Revista de lepidopterología. 4(1). 100378–100378.

Bustamante, Jacinta, Stéphanie Boisson‐Dupuis, Anne Puel, et al.. (2023). Inborn Errors of Immunity—the Sri Lankan Experience 2010–2022. Journal of Clinical Immunology. 43(8). 1858–1872. 2 indexed citations

Gkrania‐Klotsas, Effrossyni, Clare R. Sander, R. Andrés Floto, et al.. (2023). Respiratory infectious burden in a cohort of antibody deficiency patients treated with immunoglobulin replacement therapy: The impact of lung pathology and gastroesophageal reflux disease. SHILAP Revista de lepidopterología. 2(4). 100133–100133.

Döffinger, Rainer, et al.. (2021). Diminished seroconversion following a single SARS-COV-2 vaccine in ocrelizumab-treated relapsing-remitting multiple sclerosis patients. Multiple Sclerosis Journal. 28(7). 1126–1130. 5 indexed citations

Neves, João Farela, Rainer Döffinger, Catarina Martins, et al.. (2018). Novel PLCG2 Mutation in a Patient With APLAID and Cutis Laxa. Frontiers in Immunology. 9. 2863–2863. 44 indexed citations

Edgar, David, Alex Richter, Aarnoud Huissoon, et al.. (2018). Prescribing Immunoglobulin Replacement Therapy for Patients with Non-classical and Secondary Antibody Deficiency: an Analysis of the Practice of Clinical Immunologists in the UK and Republic of Ireland. Journal of Clinical Immunology. 38(2). 204–213. 24 indexed citations

Rosenberg, Jacob M., Jordan V. Price, Gabriela Barcenas‐Morales, et al.. (2015). Protein microarrays identify disease-specific anti-cytokine autoantibody profiles in the landscape of immunodeficiency. Journal of Allergy and Clinical Immunology. 137(1). 204–213.e3. 18 indexed citations

Tuohy, Orla, et al.. (2013). Immune competence after alemtuzumab treatment of multiple sclerosis. Neurology. 81(10). 872–876. 102 indexed citations

Lim, Michael Teik Chung, Hitesh Pandya, Rainer Döffinger, et al.. (2012). Specific antibody deficiency in children with chronic wet cough. Archives of Disease in Childhood. 97(5). 478–480. 8 indexed citations

10.

Isnardi, Isabelle, Yen-Shing Ng, Roja Motaghedi, et al.. (2008). IRAK-4- and MyD88-Dependent Pathways Are Essential for the Removal of Developing Autoreactive B Cells in Humans. Immunity. 29(5). 746–757. 173 indexed citations

11.

Döffinger, Rainer, Smita Y. Patel, & Dinakantha Kumararatne. (2006). Host genetic factors and mycobacterial infections: lessons from single gene disorders affecting innate and adaptive immunity. Microbes and Infection. 8(4). 1141–1150. 14 indexed citations

12.

Conacher, Margaret, Robin E. Callard, Karen A. McAulay, et al.. (2005). Epstein-Barr Virus Can Establish Infection in the Absence of a Classical Memory B-Cell Population. Journal of Virology. 79(17). 11128–11134. 17 indexed citations

13.

Jackson, Paul, David A. Lammas, A. D. Crockard, et al.. (2005). Differential response to interferon-γ therapy in a family with dominant negative partial interferon-γ receptor1 deficiency. European Journal of Pediatrics. 165(1). 71–72. 6 indexed citations

14.

Dorman, Susan E., Capucine Pïcard, David A. Lammas, et al.. (2004). Clinical features of dominant and recessive interferon γ receptor 1 deficiencies. The Lancet. 364(9451). 2113–2121. 294 indexed citations

15.

MacLennan, Calman A., Glynis Dunn, Aarnoud Huissoon, et al.. (2004). Failure to clear persistent vaccine-derived neurovirulent poliovirus infection in an immunodeficient man. The Lancet. 363(9420). 1509–1513. 109 indexed citations

16.

Döffinger, Rainer, MATTHEW HELBERT, Gabriela Barcenas‐Morales, et al.. (2003). Autoantibodies to Interferon‐γ in a Patient with Selective Susceptibility to Mycobacterial Infection and Organ‐Specific Autoimmunity. Clinical Infectious Diseases. 38(1). e10–e14. 194 indexed citations

17.

Stober, Carmel B., et al.. (2001). ATP-Mediated Killing of Intracellular Mycobacteria by Macrophages Is a P2X7-Dependent Process Inducing Bacterial Death by Phagosome-Lysosome Fusion. The Journal of Immunology. 167(6). 3300–3307. 203 indexed citations

18.

Edgar, David, Jon Pritchard, David A. Lammas, et al.. (2001). Interferon-γ receptor deficiency mimicking Langerhans’ cell histiocytosis. The Journal of Pediatrics. 139(4). 600–603. 24 indexed citations

19.

Wood, Philip, et al.. (2001). A mutation in Bruton’s tyrosine kinase as a cause of selective anti-polysaccharide antibody deficiency. The Journal of Pediatrics. 139(1). 148–151. 42 indexed citations

20.

Catty, D., et al.. (1996). Candidate antigens for improved serodiagnosis of tuberculosis. Tubercle and Lung Disease. 77(2). 136–145. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact